<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="/prwebFeeds.xsl"?>
<rss version="2.0">
  <channel>
    <title>PRWeb.com Press Release Feed - PRWeb Press Release Account Feed</title>
    <link>http://www.prweb.com</link>
    <description>PRWeb.com Press Release Feed - Press Releases</description>
    <language>en</language>
    <image>
      <title>PRWeb Distribution Newswire</title>
      <url>http://www.prweb.com/images_v4/prweb_logo_hv.jpg</url>
      <link>http://www.prweb.com</link>
      <width>200</width>
      <height>46</height>
    </image>
    <managingEditor>xml@emediawire.com</managingEditor>
    <webMaster>xml@emediawire.com</webMaster>
    <ttl>30</ttl>

<item>
    <title>VeraLight Closes $5 Million in Series A Financing</title>
    <link>http://www.prweb.com/releases/2005/09/prweb288896.htm</link>
    <description>
        <![CDATA[  <P>VeraLight, a pioneer in the development of a groundbreaking diabetes screening device, has closed $5 million in Series A funding from an investor syndicate headed by vSpring Capital. vSpring was joined by Wasatch Venture Fund, Dow Chemical Company and the Southern Ute Growth Fund. (PRWeb Sep 26, 2005)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2005/09/prweb288896.htm">http://www.prweb.com/releases/2005/09/prweb288896.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2005/09/prweb288896.htm</guid>
</item>

</channel>
</rss>